PrezentacjaprogramuPowerPoint-Yola：prezentacjaprogramuPowerPoint约拉.ppt

The long-term prognosis is not predictable. Some researchers have found that the prognosis is worse when the retina of the eyes are affected or if the aorta is damaged or when aneurysms develop. ? The effects of Takayasu arteritis vary greatly from patient to patient. These effects frequently depend on the impaired blood supply to body tissues (such as the brain leading to strokes or spinal cord leading to paralysis). Angioplasty is an accepted and successful treatment of patients with Takayasu arteritis, especially after the acute inflammatory phase has abated. The best results have been obtained with short-segment stenoses, particularly in the iliac and renal arteries. Angioplasty is generally contraindicated during the acute phase of the disease. Stent use is reported in small numbers of cases as well. Complications: * Congestive heart failure due to aortic insufficiency, myocarditis, and/or hypertension * Aortic aneurysms, thrombus formation, and rupture * Ischemic stroke * Clinically silent progressive disease and morbidity resulting from treatment medications (take into account with long-term treatment plans) Prognosis: * TA is a chronic relapsing disease. Over half of patients with TA achieve control on corticosteroids alone; however, their relapse rate is high and they require long periods of steroid treatment. verll prgnosis in individuals with TA relates to the degree of vascular and end-organ damage, specifically retinal vasculopathy, aortic insufficiency, aortic aneurysms, and hypertension. * Survival rate at 15 years is as high as 95%. * Of patients with TA who are treated with glucocorticoids, 60% respond; however, as many as 40% relapse on tapering steroids. Picture 1. Complete occlusion of the left common carotid artery in a 48-year-old woman with Takayasu disease. Also note narrowing of the origin of the right subclavian artery and a narrowed small vessel with subsequent aneurysmal dilatation on the right side